Kapinegowda Shashikala Thuraganur, Anandswamy Tejesh Channasandra, Narayanappa Vijaya Hanumanthappa, Kumar Sachin, Hatti Prashant
Department of Anaesthesia, Mysore Medical College and Research Institute, Mysore, Karnataka, India.
Department of Anaesthesia, MS Ramaiah Medical College, Bangalore, Karnataka, India.
Anesth Essays Res. 2017 Oct-Dec;11(4):847-853. doi: 10.4103/aer.AER_257_16.
Spinal anesthesia is preferred technique of choice in infraumbalical surgeries. Limitation of this technique is shorter duration of analgesia, so various adjuvants have been used with intrathecal bupivacaine such as fentanyl, clonidine, and dexmedetomidine. Dexmedetomidine is a highly selective alpha 2 adrenergic agonist. The aim of our study was to know the effect of different doses of dexmedetomidine on intrathecal bupivacaine.
The prospective, randomized, double-blind study was conducted in tertiary health care center, on ninety patients of the American Society of Anesthesiology Class I and II, of age group 18-60 years of either sex. They were randomly allocated into three groups. Group BD ( = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 5 μg (0.5 ml), Group BD ( = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 10 μg (0.5 ml), Group BD ( = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 15 μg (0.5 ml) administered intarthecally. The onset and maximum level of sensory block, time to reach maximum level of sensory block, time of two-segment sensory regression, the total duration analgesia, time of rescue analgesia, onset and duration of motor block and heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, respiratory rate, and oxygen saturation were recorded at various intervals. Moreover, any adverse effects such as bradycardia, hypotension, nausea, vomiting, and sedation were recorded.
The onset time of sensory block in Group D-2.76 ± 1.32, Group D-2.45 ± 1.50, and Group D-1.86±0.93, which is statistically significant ( = 0.025). The time taken for two-segment sensory regression Group D-96.66 ± 33.67, Group D-116.80 ± 36.27, and Group D 120.96 ± 30.24, ( = 0.014). The time taken for complete sensory recovery in Group D-319.83 ± 61.41, Group D-336.13 ± 61.38, and Group D-415.20 ± 96.6, which is statistically highly significant ( = 0.000). Time for rescue analgesia in Group D-377.46 ± 60.05, in Group D-401.60 ± 61.11, and in Group D-517.96 ± 97.30, which is statistically highly significant ( < 0.000).
We concluded that there was decrease in onset of sensory and motor blockade with the prolongation of duration of anesthesia and analgesia in a dose-dependent manner.
脊髓麻醉是脐下手术首选的麻醉技术。该技术的局限性在于镇痛持续时间较短,因此已将多种佐剂与鞘内布比卡因联合使用,如芬太尼、可乐定和右美托咪定。右美托咪定是一种高度选择性的α2肾上腺素能激动剂。我们研究的目的是了解不同剂量的右美托咪定对鞘内布比卡因产生的影响。
在三级医疗保健中心对90例年龄在18至6 ~ 0岁之间、美国麻醉医师协会分级为I级和II级的患者进行了前瞻性、随机、双盲研究,患者性别不限。他们被随机分为三组。BD1组(n = 30):鞘内注射布比卡因12.5 mg(2.5 ml)+右美托咪定5 μg(0.5 ml);BD2组(n = 30):鞘内注射布比卡因12.5 mg(2.5 ml)+右美托咪定10 μg(0.5 ml);BD3组(n = 30):鞘内注射布比卡因12.5 mg(2.5 ml)+右美托咪定15 μg(0.5 ml)。在不同时间间隔记录感觉阻滞的起效时间和最高平面、达到感觉阻滞最高平面的时间、两个节段感觉消退的时间、总镇痛持续时间、补救镇痛时间、运动阻滞的起效时间和持续时间以及心率、收缩压、舒张压、平均动脉压、呼吸频率和血氧饱和度。此外,记录任何不良反应,如心动过缓、低血压、恶心、呕吐和镇静。
D1组感觉阻滞的起效时间为2.76±1.32分钟,D2组为2.45±1.50分钟,D3组为1.86±0.93分钟,差异具有统计学意义(P = 0.025)。两个节段感觉消退的时间,D1组为96.66±33.67分钟,D2组为116.80±36.27分钟,D3组为120.96±30.24分钟,(P = 0.014)。完全感觉恢复的时间,D1组为319.83±61.41分钟,D2组为336.13±61.38分钟,D3组为415.20±96.6分钟,差异具有高度统计学意义(P = 0.000)。补救镇痛的时间,D1组为377.46±60.05分钟,D2组为401.60±61.11分钟,D3组为517.96±97.30分钟,差异具有高度统计学意义(P < 0.000)。
我们得出结论,随着麻醉和镇痛持续时间的延长,感觉和运动阻滞的起效时间呈剂量依赖性降低。